Compound class:
Synthetic organic
Comment: BT-33 is a fluorinated macrobicyclic oxepanoprolinamide antibacterial compound with broad-spectrum activity against multidrug-resistant (MDR) bacteria [2]. It was discovered through a collaboration between the University of Illinois at Chicago and Harvard University and is one of the chemical structures claimed in patent WO2023205206A1 [1].
|
|
References |
1. Myers AG, Wu K, Tresco BC. (2023)
Lincosamides and uses thereof. Patent number: WO2023205206A1. Assignee: President and Fellows of Harvard College. Priority date: 20/04/2023. Publication date: 26/10/2023. |
2. Tresco BIC, Wu KJY, Ramkissoon A, Aleksandrova EV, Purdy M, See DNY, Liu RY, Polikanov YS, Myers AG. (2025)
Discovery of a fluorinated macrobicyclic antibiotic through chemical synthesis. Nat Chem, [Epub ahead of print]. [PMID:40055575] |